NSE ScannerOpen the scanner

Pharmaceuticals · Pharmaceuticals: Major · NSE: SUNREST · data 2026-10-30

Sunrest Lifescience Limited

₹39.25+17.16% on 30 OctHealth: Strong 7.9/10

In plain words

Price: 27.3% below its 52-week high of ₹54.

A description of the data, not a recommendation.

Open full analysis — chart, results, balance sheet, red flags →

Key figures

Price
₹39.25
Market cap
₹14 cr
P/E
4.5
P/B
0.8
ROE
22.4%
ROCE
25.9%
Debt / equity
0.85
Dividend yield
0.00%
1-year return
-6.5%
52-week high
₹54
52-week low
₹29.55
Operating margin
11.3%

Growth

Revenue (last 12 months)₹71 cr
Net profit (last 12 months)₹4 cr
Sales growth, 3 years (yearly)43.4%
Profit growth, 3 years (yearly)26.3%

Smart-money activity

5/100 · Weak over the last ~60 sessions

A description of recorded activity (delivery, deals, insider buys, fund holding, pledges), not a recommendation. Today's most active stocks.

Common questions

Is Sunrest Lifescience Limited debt-free?

Its latest reported debt-to-equity ratio is 0.85.

What is Sunrest Lifescience Limited's P/E ratio?

About 4.5, based on the last 12 months' earnings and a price of ₹39.25 (data 2026-10-30).

What is the 52-week high and low of Sunrest Lifescience Limited?

The 52-week high is ₹54 and the 52-week low is ₹29.55.

Similar companies

Biofil Chemicals & Pharmaceuticals Ltd. (BIOFILCHEM) · Medicamen Organics Ltd. (MEDIORG) · Medi-Caps Ltd. (MEDICAPQ) · Lasa Supergenerics Ltd. (LASA) · Ortin Global Ltd (ORTINGLOBE)

The full analysis has the price chart, every quarterly result with YoY/QoQ growth, the balance sheet and cash flow with an accounting red-flag check, shareholding quarter by quarter with big investors, news, filings and bulk/block deals.

Open SUNREST in NSE Scanner →
Share on WhatsAppShare on Telegram